Powered by Smartsupp

High blood pressure and microcirculation: what does PBM research show?

KINGRAY Academy logo
KINGRAY ACADEMY
BLOOD PRESSURE · MICROCIRCULATION · LIGHT RESEARCH

High blood pressure and light: connecting physiology and research

Do you have high blood pressure and wonder whether laser blood irradiation could help? Research has reported interesting findings, but the certainty of the evidence remains very low. Understanding them starts with the interaction between the heart, blood, large arteries and the smallest vessels. [1][9]

Select a question to scroll to its answer within this article.

Author: Ing. František Kokoš
Updated:

Why does blood pressure rise?

Blood pressure depends on the amount of blood pumped by the heart and the resistance of the circulation. Small arteries and arterioles account for an important share of this resistance. Persistent constriction or changes in their walls make the heart pump against greater resistance. Systolic pressure is the pressure during a heartbeat; diastolic pressure is the pressure between beats. [2][3]

Several influences usually interact: heredity, age, excess weight, too much salt, inactivity, alcohol and sleep disorders. The kidneys, hormones and nervous system also regulate pressure. Sometimes there is a specific cause, such as kidney disease or sleep apnoea. A normal pulse does not exclude high blood pressure. [2]

Why does higher pressure not always mean better blood flow?

Microcirculation is blood flow through the smallest vessels. Capillaries allow oxygen, nutrients and metabolic products to pass between blood and tissue. The volume and distribution of blood within an organ matter, together with the vessels’ ability to respond to the current needs of its cells. [6]

In hypertension, small vessels may narrow, their walls may remodel and fewer capillaries may participate in blood flow. A functional reduction in perfusion is different from the physical loss of capillaries. In 2008, Cheng and colleagues found functional capillary rarefaction associated with endothelial function in people with mildly elevated pressure. This was an observational study. [4]

The relationship runs both ways: increased small-vessel resistance can contribute to higher pressure, and high pressure can further damage the vessels. The number on a monitor does not, by itself, reveal how much oxygen reaches every tissue. [3][4][6]

What role do red cells and “thick blood” play?

Red blood cells carry oxygen in haemoglobin and change shape to pass through narrow capillaries. Their deformability, reversible aggregation and the properties of plasma all affect flow. In men with untreated hypertension, lower skin capillary density was associated with greater viscosity at low flow rates and increased red-cell aggregation. Association alone does not establish causation. [5]

Viscosity describes resistance to flow. Blood clotting is a different process, and a red-cell aggregate is not automatically a blood clot. Oxygen delivery also depends on haemoglobin, oxygen uptake in the lungs and actual blood flow. A microscope image of a blood drop alone cannot establish the cause of high blood pressure. [3][5][6]

Can light reduce viscosity? In the laboratory work by Mi and colleagues, favourable changes were observed in blood samples outside the body. This cannot establish clot removal, justify stopping anticoagulants or guarantee a blood pressure reduction in humans. [7]

Can lasers clear plaques from arteries?

These studies did not demonstrate removal of atherosclerotic plaque. Changes in flow, red cell flexibility or NO are not the same outcome as plaque regression. Managing pressure, cholesterol, diabetes and smoking remains part of established care. [3][7][9]

What happens to the heart, kidneys and vessels?

The left ventricle pumps blood around the body. Sustained pressure overload can thicken its muscle and make relaxation and filling more difficult. Large arteries can lose elasticity and become less able to cushion each pressure wave. These changes do not develop equally in everyone, but they help explain the value of early treatment. [3]

The kidneys regulate salt and water. High pressure can damage their small vessels; impaired kidney function can then raise pressure further. Long-term hypertension also increases the risk of stroke and eye damage. Protecting organs is therefore a more meaningful goal than a single lower reading. [1][10]

Depending on the situation, assessment includes blood and urine tests, an ECG and sometimes a heart ultrasound. Pressure may fall before structural changes improve; advanced damage may not be fully reversible. [3]

Organ protection and prevention: the studies discussed did not demonstrate fewer heart attacks or strokes, or lasting kidney protection. Measuring NO or pressure is an intermediate step; organ protection needs separate evidence over longer follow-up. [3][8][9][10]

Can laser therapy lower blood pressure? What does research show?

Photobiomodulation research examines cellular and vascular responses to light, including NO signalling. Results depend on the parameters and application method. The following studies represent different levels of evidence and do not measure identical outcomes. [7][8][9]

Laboratory study · Mi et al., 2004

Researchers irradiated human blood samples outside the body. In samples with impaired properties they observed changes in viscosity and red-cell deformability. The study did not measure a patient’s blood pressure or protection of their organs. [7]

Clinical study · Zvegintsev, 2025

According to the published abstract, 100 patients aged 18–45 with resistant hypertension were randomly divided into two groups of 50. One received medication plus intravenous laser treatment; the other received medication alone. After 2 months, the authors reported better attainment of target pressure and changes in some vascular markers. Assessment included 24-hour monitoring. This was an adjunct to treatment; this summary is based on the abstract, which does not allow a full assessment of the methods. [8]

Evidence synthesis · Espósito et al., 2025

The systematic review included 4 randomised clinical trials and 5 experimental animal studies. It reported a possible reduction in pressure, but rated the certainty of evidence as very low and identified high risk of bias in the clinical trials. The varied protocols do not validate a single home device. [9]

Animal model · Oishi et al., 2024

In rats with diet-induced obesity, 660 nm light limited the rise in systolic pressure and improved NO and endothelial-function markers. This is an encouraging mechanistic finding from an animal model, not an established human dose or expected clinical effect. [12]

Human pilot study · Lizarelli et al., 2021

The study included 36 women, six per group, and compared routes including nasal mucosa, under the tongue and skin over an artery. Participants were selected without a history of hypertension. Pressure findings were heterogeneous; the small groups do not establish hypertension treatment. The work nevertheless demonstrates that the nasal route has genuinely been investigated in humans. [13]

Duration of benefit: two months of follow-up or a lower reading after one application does not demonstrate a lasting improvement after procedures stop. Future studies need longer follow-up, inactive controls and records of medication changes and adverse events. [8][9]

Why are ILIB and an intranasal laser different?

In intravenous laser blood irradiation, ILIB, an optical fibre delivers light into a vein in a healthcare setting. With application through skin or the nasal lining, light first passes through other tissues. The amount of energy and the structures it reaches therefore differ. [8][9]

The resistant-hypertension study described here tested intravenous application. It does not establish the effectiveness of a nasal probe, LED panel or another home device. Similar light colour or the same treatment time does not guarantee the same result. The related article on application methods explains these differences. [8][9]

Heart series: Methods of laser blood irradiation

Research uses different sources: intravenous optical fibres, local lasers, LED systems and applicators on skin or mucosa. The nasal pilot differs from the clinical trial of intravenous ILIB. The same light colour does not guarantee the same dose or clinical result. [8][13][14]

How does light reach tissues, and what does NO do?

Some incident light is reflected; some is scattered or absorbed in tissue. The amount reaching target cells depends on wavelength, power per area, duration, application site and tissue properties. A surface dose is not automatically the dose in a deeper vessel. Panels, wrist applicators and nasal probes therefore cannot be considered equivalent without measurements. [14]

Nitric oxide (NO) participates in vascular signalling: it helps relax smooth muscle in the vessel wall. Researchers investigate whether PBM affects NO availability, oxidative stress and endothelial function. A favourable change in this regulation is biologically interesting; it does not alone establish lasting treatment of hypertension. [8][12]

How can you tell whether pressure is really changing?

Use a validated upper-arm monitor with a correctly sized cuff. Sit quietly beforehand, support your back and arm, keep your feet on the floor and avoid talking during measurement. European guidance describes two readings 1–2 minutes apart, morning and evening, for at least 3 and preferably up to 7 days, followed by assessment of the average. [3]

Record the time, medicines taken and unusual circumstances. One lower reading after rest or device use does not demonstrate a lasting device effect. Where findings are unclear, a clinician may arrange 24-hour ambulatory monitoring. [3]

What can support pressure control and small-vessel health now?

The foundations include appropriate regular activity, less salt and alcohol, weight management where needed, not smoking and addressing sleep disorders. Taking prescribed treatment consistently and managing other risks, such as diabetes and blood lipids, also matter. Advice must suit the individual’s health. [1][2][3]

If pressure remains high despite medication, a clinician checks measurement technique, medicine use and combinations, and possible underlying causes. Do not increase doses or stop treatment on the basis of one reading. An experimental adjunct should be assessed alongside standard care. [3][8][9]

Do not stop medication yourself after photobiomodulation. Treatment decisions rely on repeated home or 24-hour measurements, symptoms and overall risk, not one favourable result after a procedure. [3][8][9]

Safety: medication, low pressure, contraindications and heat

Pressure that is too low: the exact risk of PBM combined with antihypertensive drugs is unknown. Medication itself can lower pressure excessively. If dizziness, weakness or fainting occurs, stop the application, record blood pressure and seek appropriate medical assistance. Discuss any medication adjustment with a clinician. [15]

Pacemaker, cancer or pregnancy: the diagnosis, application site and device instructions are decisive. Rules for light cannot automatically be exchanged with those for electrical or magnetic stimulation in a combined device. Limited data are not proof of safety; the relevant healthcare professional should assess suitability. Intravenous procedures also require a healthcare setting. [14][16]

Heat and eyes: PBM is generally investigated at parameters intended for photobiological rather than thermal effects. Inappropriate power, exposure or equipment can nevertheless damage skin or eyes. Stop if burning occurs; do not direct lasers into the eyes and follow the specified protection instructions. [14][16]

Frequently asked questions

What exactly does photobiomodulation research investigate in high blood pressure?

It examines vascular lining responses, NO signalling, microcirculation and blood pressure changes at specific light parameters. These outcomes must be assessed separately. [8][9]

How can light reach blood vessels and influence microcirculation?

Some light is absorbed and scattered in tissue. Penetration depends on wavelength, dose and tissue; shining light on skin alone does not guarantee an effective dose in a deep vessel. [14]

What is nitric oxide (NO), and how is it linked to light and blood pressure?

NO is a signalling molecule that helps relax vascular smooth muscle. Research asks whether light favourably influences this regulation, not merely a single blood pressure reading. [8][12]

Is photobiomodulation studied in humans or only in animals?

Laboratory, animal and human studies exist. A 2025 review included four randomised clinical trials and five animal studies; the certainty of evidence was very low. [9]

Can photobiomodulation permanently lower systolic and diastolic pressure?

Some studies observed lower pressure. These findings do not establish a lasting reduction after application stops or a universal effect of home devices. [8][9]

Why is microcirculation important in hypertension?

The smallest vessels supply tissues and contribute to vascular resistance. Hypertension can damage them, while small-vessel changes can further promote high pressure. [3][4][6]

Can light therapy reduce blood viscosity, or “thickness”?

A laboratory study reported favourable changes in viscosity and red cell deformability. This does not establish hypertension treatment or a replacement for anticoagulant medication. [7]

Can a laser clear atherosclerotic plaques from arteries?

These studies did not demonstrate removal of atherosclerotic plaques. Small-vessel dilation, altered viscosity and plaque regression are different outcomes. [3][7][9]

Can I stop blood pressure medication after photobiomodulation?

Not on your own. The clinical trial investigated light added to medication. A clinician should adjust treatment based on repeated measurements and overall risk. [3][8][9]

Could blood pressure fall too low when combined with medication?

The exact combined risk is unknown. Blood pressure medicines can cause hypotension; dizziness, weakness or fainting require assessment and review of measurements. [15]

Which devices and application methods are used in research?

Research includes intravenous fibres, skin or mucosal applicators and other laser or LED systems. Results from a particular protocol do not automatically apply to all devices. [8][13][14]

What are the contraindications, including pacemakers, cancer or pregnancy?

The device, application, health condition and instructions matter. Without those details, these diagnoses cannot be treated as a universal prohibition or confirmation of safety. [14][16]

Could laser heat damage skin or small capillaries?

Inappropriate power, duration or equipment can damage tissue. PBM usually aims for non-thermal effects, but the term “cold laser” alone does not guarantee safety. [14][16]

Can photobiomodulation protect the kidneys, heart and brain from hypertension?

Organ protection is an important aim for future research. These changes in NO, flow or pressure do not yet establish lasting protection of the kidneys, heart and brain. [8][9][10]

Does it help prevent heart attacks and strokes?

These studies did not demonstrate fewer heart attacks or strokes. Prevention continues to rely on controlling blood pressure and other risk factors. [3][9]

What readings count as high blood pressure?

Under the European ESC 2024 guidelines, the office threshold is systolic pressure of at least 140 or diastolic pressure of at least 90 mmHg. For the home average it is 135 or 85 mmHg. Diagnosis relies on repeated readings; an individual treatment target may differ. [3]

Can I have high blood pressure without symptoms?

Yes. Hypertension often causes no obvious symptoms. Feeling well does not replace proper measurement. Fatigue or cold limbs alone do not establish hypertension or impaired microcirculation. [1][3]

This educational article explains research. Individual diagnosis and treatment require a healthcare professional; specific products are compared in our Advice section.

Sources and research

Sources checked on 10 November 2026. Clinical study [8] is summarised from its published abstract. Laboratory experiments, observational studies and clinical trials provide different levels of evidence.

  1. World Health Organization. Hypertension. 2025.
    Open source ↗
  2. NHLBI. High Blood Pressure — Causes and Risk Factors.
    Open source ↗
  3. McEvoy JW et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. European Heart Journal. 2024;45:3912–4018.
    Open source ↗
  4. Cheng C, Diamond JJ, Falkner B. Functional capillary rarefaction in mild blood pressure elevation. Clinical and Translational Science. 2008;1(1):75–79.
    Open source ↗
  5. Ciuffetti G et al. Blood rheology in men with essential hypertension and capillary rarefaction. Journal of Human Hypertension. 2002;16:533–537.
    Open source ↗
  6. Pittman RN. Regulation of Tissue Oxygenation. Morgan & Claypool Life Sciences; 2011.
    Open source ↗
  7. Mi XQ et al. In vitro effects of helium-neon laser irradiation on human blood: blood viscosity and deformability of erythrocytes. Photomedicine and Laser Surgery. 2004;22:477–482.
    Open source ↗
  8. Zvegintsev RR. Effects of intravenous laser blood irradiation on sympathoadrenal activity and endothelial dysfunction in resistant hypertension. Russian Journal of Physiotherapy, Balneology and Rehabilitation. 2025;24(2):97–106.
    Open source ↗
  9. Espósito LMB et al. Photobiomodulation Therapy in Hypertension Management—Evidence from a Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2025;14(19):6716.
    Open source ↗
  10. NIDDK. High Blood Pressure & Kidney Disease.
    Open source ↗
  11. American Heart Association. When To Call 911 About High Blood Pressure. 2025.
    Open source ↗
  12. Oishi JC et al. Long-term effects of photobiomodulation therapy on blood pressure in obese rats induced by a high-fat diet. Lasers in Medical Science. 2024;39:20. DOI: 10.1007/s10103-023-03950-8.
    Animal model of obesity: 660 nm light, blood pressure, NO and endothelial function.
    Open source ↗
  13. Lizarelli RFZ et al. A pilot study on the effects of transcutaneous and transmucosal laser irradiation on blood pressure, glucose and cholesterol in women. Heliyon. 2021;7:e07110. DOI: 10.1016/j.heliyon.2021.e07110.
    Pilot in 36 women, including nasal application and pressure measurements; not confirmation of hypertension treatment.
    Open source ↗
  14. Zein R, Selting W, Hamblin MR. Review of light parameters and photobiomodulation efficacy: dive into complexity. Journal of Biomedical Optics. 2018;23:120901. DOI: 10.1117/1.JBO.23.12.120901.
    Review of photobiomodulation parameters, dosing and light–tissue interaction.
    Open source ↗
  15. American Heart Association. Low Blood Pressure – When Blood Pressure Is Too Low.
    Official information on low blood pressure, symptoms and possible causes.
    Open source ↗
  16. U.S. Food and Drug Administration. Frequently Asked Questions About Lasers.
    Safety information on laser class, power and risks to eyes and skin.
    Open source ↗
Ing. František Kokoš
Author: Ing. František Kokoš
Ing. František Kokoš – Author of KINGRAY Academy and Advice Corner
Technician, nutrition adviser (graduate of the 150-hour Welko retraining programme, 2025) and creator of the KINGRAY nutraceuticals concept. Years of developing the BIOquant medical device and working with blood rheology and tissue oxygenation led him to realise that bodily health requires the full picture – linking microcirculation, cellular energy and proper nutrition. In his articles, he looks for the balance where the body understands and cooperates with us.
He is the author of the book Liečba svetlom (Light Therapy, ISBN 978-80-970512-0-4), co-author of the publication BIOquant – polovodičová laserová terapia (BIOquant – Semiconductor Laser Therapy, ISBN 978-80-970512-2-8), and originator of patents in light technologies (US9731145B2, SK5457Y1).
%s ...
%s
%image %title %code %s
%s